Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic's many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
Search Results 51-60 of 62 for Oral
"When cancer cells spread beyond the primary tumor, standard intravenous or oral chemotherapy drugs won't be able to kill them," Dr.
"They are more likely to be asymptomatic or monosymptomatic, with, for example, abdominal pain, recurrent oral ulcers, poor tooth enamel, skin rash or celiac hepatitis.
Those patients were separated into two groups: those who were treated with a Food and Drug Administration-approved oral medication for depression at the time of TBI and those who were not.
Dec. 03, 2018 Mayo researchers say oral apixaban safe and effective for treating blood clots in cancer patients SAN DIEGO ??
May 06, 2016 Reversing NOACs presents challenges Unlike warfarin, novel oral anticoagulants (NOACs) have no universal antidote.
In high-risk regions, major risk factors include exposure to carcinogens, poor oral hygiene, opium use, poor nutrition and thermal damages caused by hot beverages.
Novel oral anticoagulants have not been used in patients with bioprosthetic valves; their role in bioprosthetic thrombosis is entirely unknown, and they cannot be recommended at this time.
The newer oral anticoagulant agents such as dabigatran, rivaroxaban, and apixaban also have not been specifically studied in CHD patients.
Nov. 20, 2017 New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows ROCHESTER, Minn. ?
. , chair of Oral and Maxillofacial Surgery at Mayo Clinic's campus in Rochester, Minnesota.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.